Featured News

BPC is pleased to share perspective on biosimilars and policy issues through opinion editorials and interviews with interested outlets. BPC can be contacted for comments and interviews through the contact us page. Below please find articles on relevant biosimilar topics.

Contributed Content

January 28, 2019 The Center for Biosimilars, Proposed CMS Changes Are the Wrong Way to Save Money and Will Harm Patients and Providers

September 20, 2018 Comment Submission, Facilitating Competition and Innovation in the Biological Products Marketplace

September 3, 2018 The Hill, Biosimilar Medicines are the Key to Success

July 2, 2018 The Center for Biosimilars, Biosimilar Nonmedical Switching Must Never Undermine Patient Safety

June 21, 2018 Letter to the Editor: New England Journal of Medicine, Friction in the Path to Use of Biosimilar Drugs

June 9, 2017 Morning Consult, Drug Data Belongs in the Hands of Physicians and Patients, Angus Worthing

Mentions

September 4, 2018 S&P Global Market Intelligence: Drugmakers, Public Weigh In On Efforts to Boost US Biosimilar Competition

June 21, 2018 Healio, Concerns over nonmedical switching of biologics spur physician guidelines

June 21, 2018 The Center for Biosimilars, BPC’s Nonmedical Switching Guidelines Seek to Preserve Physician–Patient Relationship

July 27, 2017 Healio, Unknowns of interchangeability likely not problematic with monitoring, FDA guidance

July 27, 2017 Healio, Patient access, health care cost reduction spur biosimilars development

July 26, 2017 Healio, Physicians cautiously optimistic as they gain knowledge of biosimilars

Stay Informed View the latest newsletter

To receive regular newsletters and periodic alerts from the BPC, enter your email address in the form below: